1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  6. QuickLinks
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  6. QuickLinks
  1. Launch
  1. My Preqin
Book a demo

CorriXR Therapeutics

Have updates for this profile?  Please contribute data

About Employee data
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2022

Location

Newark DE US

Primary Industry

Biotechnology

About

Based in Delaware, US, and founded in 2022, CorriXR Therapeutics is on the clinical frontier of gene editing as a transformative research-based biotechnology company. The company was founded by its CEO Eric B Kmiec. In October 2022, CorriXR Therapeutics raised USD 5 million in seed funding led by Brookhaven Bio and Christiana Care Health System. The company uses CRISPR/Cas gene editing technology to develop new, clinically relevant oncologic therapeutics in areas of unmet medical need, starting with squamous cell carcinoma of the lung. It uses technologies that knock out NRF2 that develop tumors.
Current Investors
Christiana Care Health System, Brookhaven Bio, Cortado Ventures

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment
Website
www.corrixr.com
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Employee Data

Employee Graph

Want to see the Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo